Influence of Genetic Polymorphisms of the Renin-Angiotensin System on IgA Nephropathy
Authors:
- K. IvensKIK. Ivens
- W. KreusserWKW. Kreusser
- M. KochMKM. Koch
- N. Klein-VehneNKN. Klein-Vehne
- B. GrabenseeBGB. Grabensee
- P. HeeringPHP. Heering
- 1 April 2004
- journal article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 24 (2) , 258-267
Abstract
Background: We evaluated the impact of the three major genetic polymorphisms of the renin-angiotensin system [angiotensinogen (AGT) gene M235T, angiotensin-converting enzyme (ACE) gene-I/D and angiotensin II-type 1 receptor (AT1R) gene A1166C polymorphisms] as risk factors in IgA nephropathy. Methods: The clinical course of 107 patients with biopsy proven IgA nephropathy followed up for 6.6 ± 5.8 years was examined. The genetic polymorphisms were determined by PCR amplification. Results: The allele frequencies of the polymorphisms studied were similar in patients and control subjects. AGT-M235T genotype was associated with the presence of nephrotic syndrome (p < 0.05), correlated to the number of antihypertensive drugs agents taken (p < 0.01) and influenced the rate of deterioration of renal function (p < 0.05). Combined analysis of AGT-M235T and ACE-I/D polymorphisms detected an interaction on affecting progression (p < 0.05). ACE-inhibition had a more pronounced effect in certain AGT-M235T and ACE-I/D genotypes (p < 0.05) and their combined analysis showed a synergistic effect (p < 0.01). No association between AT1R-A1166C polymorphism and any of the parameters studied was observed. Conclusions: Our results suggest that angiotensinogen-M235T polymorphism is an important marker of progression in IgA nephropathy in Caucasian patients, especially when analyzed in combination with ACE-I/D polymorphism.Keywords
This publication has 21 references indexed in Scilit:
- Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expressionKidney International, 2001
- Genetic variation in the renin-angiotensin system and athletic performanceEuropean Journal of Applied Physiology, 2000
- Angiotensin-Converting Enzyme Gene Polymorphism Determines the Antiproteinuric and Systemic Hemodynamic Effect of Enalapril in Patients with Proteinuric Renal DiseaseKidney and Blood Pressure Research, 1998
- Visualisation and quantification of rates of atrophy in Alzheimer's diseaseThe Lancet, 1996
- Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarctionThe Lancet, 1994
- Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular HypertrophyNew England Journal of Medicine, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- Absence of linkage between the angiotensin converting enzyme locus and human essential hypertensionNature Genetics, 1992